Abstract
Intragenic homozygous deletions in the Large gene are associated with a severe neuromuscular phenotype in the myodystrophy (myd) mouse. These mutations result in a virtual lack of glycosylation of αdystroglycan. Compound heterozygous LARGE mutations have been reported in a single human patient, manifesting with mild congenital muscular dystrophy (CMD) and severe mental retardation. These mutations are likely to retain some residual LARGE glycosyltransferase activity as indicated by residual α-dystroglycan glycosylation in patient cells. We hypothesized that more severe LARGE mutations are associated with a more severe CMD phenotype in humans. Here we report a 63-kb intragenic LARGE deletion in a family with Walker-Warburg syndrome (WWS), which is characterized by CMD, and severe structural brain and eye malformations. This finding demonstrates that LARGE gene mutations can give rise to a wide clinical spectrum, similar as for other genes that have a role in the post-translational modification of the α-dystroglycan protein. © Springer-Verlag 2007.
Cite
CITATION STYLE
van Reeuwijk, J., Grewal, P. K., Salih, M. A. M., Beltrán-Valero de Bernabé, D., McLaughlan, J. M., Michielse, C. B., … Voit, T. (2007). Intragenic deletion in the LARGE gene causes Walker-Warburg syndrome. Human Genetics, 121(6), 685–690. https://doi.org/10.1007/s00439-007-0362-y
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.